A Comparison of Patient Adherence and Preference of Packaging Method for Oral Anticancer Agents Using Conventional Pill Bottles versus Daily Pill Boxes
Completed
- Conditions
- Advanced solid tumorsCancerSolid tumours
- Registration Number
- ISRCTN74558413
- Lead Sponsor
- Princess Margaret Hospital (Canada)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Patients were included in this study if they:
1. Provided informed consent
2. Were capable of reading and writing in English
3. Were greater than 18 years of age with solid tumors
4. Were planned to receive at least 2 consecutive cycles of capecitabine
Exclusion Criteria
Patients taking other oral anticancer medications such as temozolomide, tamoxifen and arimidex, were not felt to be suitable for the present study since these oral medications are already dispensed in unit dose packages.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient adherence was similiar.
- Secondary Outcome Measures
Name Time Method Patients more satisfied with daily pill boxes than conventional pill bottles.